125 related articles for article (PubMed ID: 38105033)
1. Enhanced cannabis timeline followback (EC-TLFB): Comprehensive assessment of cannabis use including standard THC units and validation through biological measures.
Petrilli K; Lawn W; Lees R; Mokrysz C; Borissova A; Ofori S; Trinci K; Dos Santos R; Leitch H; Soni S; Hines LA; Lorenzetti V; Curran HV; Freeman TP
Addiction; 2024 Apr; 119(4):772-783. PubMed ID: 38105033
[TBL] [Abstract][Full Text] [Related]
2. Recent Self-Reported Cannabis Use Is Associated With the Biometrics of Delta-9-Tetrahydrocannabinol.
Smith MJ; Alden EC; Herrold AA; Roberts A; Stern D; Jones J; Barnes A; O'Connor KP; Huestis MA; Breiter HC
J Stud Alcohol Drugs; 2018 May; 79(3):441-446. PubMed ID: 29885152
[TBL] [Abstract][Full Text] [Related]
3. Correlations and agreement between delta-9-tetrahydrocannabinol (THC) in blood plasma and timeline follow-back (TLFB)-assisted self-reported use of cannabis of patients with cannabis use disorder and psychotic illness attending the CapOpus randomized clinical trial.
Hjorthøj CR; Fohlmann A; Larsen AM; Arendt M; Nordentoft M
Addiction; 2012 Jun; 107(6):1123-31. PubMed ID: 22151583
[TBL] [Abstract][Full Text] [Related]
4. Self-report methodology for quantifying standardized cannabis consumption in milligrams delta-9-tetrahydrocannabinol.
Larsen SF; Johnson AJ; Larimer ME; Dager SR; Kleinhans NM
Am J Drug Alcohol Abuse; 2023 Nov; 49(6):723-732. PubMed ID: 37506343
[No Abstract] [Full Text] [Related]
5. Assessment of Orally Administered Δ9-Tetrahydrocannabinol When Coadministered With Cannabidiol on Δ9-Tetrahydrocannabinol Pharmacokinetics and Pharmacodynamics in Healthy Adults: A Randomized Clinical Trial.
Zamarripa CA; Spindle TR; Surujunarain R; Weerts EM; Bansal S; Unadkat JD; Paine MF; Vandrey R
JAMA Netw Open; 2023 Feb; 6(2):e2254752. PubMed ID: 36780161
[TBL] [Abstract][Full Text] [Related]
6. Urinary Excretion Profile of Cannabinoid Analytes Following Acute Administration of Oral and Vaporized Cannabis in Infrequent Cannabis Users.
Sholler DJ; Zamarripa CA; Spindle TR; Martin EL; Kuntz D; Vandrey R; Grabenauer M
J Anal Toxicol; 2022 Oct; 46(8):882-890. PubMed ID: 35770374
[TBL] [Abstract][Full Text] [Related]
7. Using ecological momentary assessment and a portable device to quantify standard tetrahydrocannabinol units for cannabis flower smoking.
Trull TJ; Freeman LK; Fleming MN; Vebares TJ; Wycoff AM
Addiction; 2022 Aug; 117(8):2351-2358. PubMed ID: 35293047
[TBL] [Abstract][Full Text] [Related]
8. An Approach to Biomarker Discovery of Cannabis Use Utilizing Proteomic, Metabolomic, and Lipidomic Analyses.
Hinckley JD; Saba L; Raymond K; Bartels K; Klawitter J; Christians U; Hopfer C
Cannabis Cannabinoid Res; 2022 Feb; 7(1):65-77. PubMed ID: 33998853
[No Abstract] [Full Text] [Related]
9. Validation of self-reported cannabis dose and potency: an ecological study.
van der Pol P; Liebregts N; de Graaf R; Korf DJ; van den Brink W; van Laar M
Addiction; 2013 Oct; 108(10):1801-8. PubMed ID: 23627816
[TBL] [Abstract][Full Text] [Related]
10. Plasma and urine profiles of Delta9-tetrahydrocannabinol and its metabolites 11-hydroxy-Delta9-tetrahydrocannabinol and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol after cannabis smoking by male volunteers to estimate recent consumption by athletes.
Brenneisen R; Meyer P; Chtioui H; Saugy M; Kamber M
Anal Bioanal Chem; 2010 Apr; 396(7):2493-502. PubMed ID: 20112012
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Outcomes of Adolescent THC Exposure on Translational Cognitive Measures in Adulthood in an Animal Model and Computational Assessment of Human Data.
Ferland JN; Ellis RJ; Betts G; Silveira MM; de Firmino JB; Winstanley CA; Hurd YL
JAMA Psychiatry; 2023 Jan; 80(1):66-76. PubMed ID: 36416863
[TBL] [Abstract][Full Text] [Related]
12. Estimating THC Consumption from Smoked and Vaped Cannabis Products in an Online Survey of Adults Who Use Cannabis.
Budney AJ; Borodovsky JT; Struble CA; Habib MI; Shmulewitz D; Livne O; Aharonovich E; Walsh C; Cuttler C; Hasin DS
Cannabis Cannabinoid Res; 2024 Apr; 9(2):688-698. PubMed ID: 36521175
[No Abstract] [Full Text] [Related]
13. The Utility of THC Cutoff Levels in Blood and Saliva for Detection of Impaired Driving.
Di Ciano P; Brands B; Fares A; Wright M; Stoduto G; Byrne P; McGrath M; Hasan OSM; Le Foll B; Wickens CM
Cannabis Cannabinoid Res; 2023 Jun; 8(3):408-413. PubMed ID: 36730769
[No Abstract] [Full Text] [Related]
14. A Double-Blind, Randomized, Controlled Crossover Trial of Cannabis in Adults with Tourette Syndrome.
Abi-Jaoude E; Bhikram T; Parveen F; Levenbach J; Lafreniere-Roula M; Sandor P
Cannabis Cannabinoid Res; 2023 Oct; 8(5):835-845. PubMed ID: 36040329
[No Abstract] [Full Text] [Related]
15. Driving under the influence of cannabis: A 5-year retrospective Italian study.
Favretto D; Visentin C; Aprile A; Terranova C; Cinquetti A
Forensic Sci Int; 2023 Dec; 353():111854. PubMed ID: 37922577
[TBL] [Abstract][Full Text] [Related]
16. Exploring survey methods for measuring consumption quantities of cannabis flower and concentrate products.
Borodovsky JT; Struble CA; Habib MI; Hasin DS; Shmulewitz D; Walsh C; Livne O; Aharonovich E; Budney AJ
Am J Drug Alcohol Abuse; 2023 Nov; 49(6):733-745. PubMed ID: 37774316
[No Abstract] [Full Text] [Related]
17. A naturalistic study of orally administered vs. inhaled legal market cannabis: cannabinoids exposure, intoxication, and impairment.
Bidwell LC; Karoly HC; Torres MO; Master A; Bryan AD; Hutchison KE
Psychopharmacology (Berl); 2022 Feb; 239(2):385-397. PubMed ID: 34708254
[TBL] [Abstract][Full Text] [Related]
18. Differences in prescribed medicinal cannabis use by cannabinoid product composition: Findings from the cannabis as medicine survey 2020 (CAMS-20) Australia-wide study.
Trevitt BT; Bailey S; Mills L; Arkell TR; Suraev A; McGregor IS; Lintzeris N
PLoS One; 2024; 19(2):e0297092. PubMed ID: 38354169
[TBL] [Abstract][Full Text] [Related]
19. THC and THC-COOH hair concentrations: Influence of age, gender, consumption habits, cosmetics treatment, and hair features.
Vaiano F; Scuffi L; Lachi A; Trignano C; Argo A; Mari F; Bertol E
J Pharm Biomed Anal; 2023 Feb; 225():115237. PubMed ID: 36638568
[TBL] [Abstract][Full Text] [Related]
20. Knowledge of Tetrahydrocannabinol and Cannabidiol Levels Among Cannabis Consumers in the United States and Canada.
Hammond D; Goodman S
Cannabis Cannabinoid Res; 2022 Jun; 7(3):345-354. PubMed ID: 33998866
[No Abstract] [Full Text] [Related]
[Next] [New Search]
